Jefferies analyst Jack Slevin lowered the price target on Astrana Health, Inc (NASDAQ: ASTH) to $47.00 (from $62.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE